Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction

Open Heart. 2021 May;8(1):e001650. doi: 10.1136/openhrt-2021-001650.

Abstract

Background: In patients with ST-segment elevation myocardial infarction (STEMI), it is unknown how patient delay modulates the beneficial effects of timely reperfusion.

Aims: To assess the prognostic significance of a contact-to-balloon time of less than 90 min on in-hospital mortality in different categories of symptom-onset-to-first-medical-contact (S2C) times.

Methods: A total of 20 005 consecutive patients from the Feedback Intervention and Treatment Times in ST-segment Elevation Myocardial Infarction (FITT-STEMI) programme treated with primary percutaneous coronary intervention (PCI) were included.

Results: There were 1554 deaths (7.8%) with a J-shaped relationship between mortality and S2C time. Mortality was 10.0% in patients presenting within 1 hour, and 4.9%, 6.0% and 7.3% in patient groups with longer S2C intervals of 1-2 hours, 2-6 hours and 6-24 hours, respectively. Patients with a short S2C interval of less than 1 hour (S2C<60 min) had the highest survival benefit from timely reperfusion with PCI within 90 min (OR 0.27, 95% CI 0.23 to 0.31, p<0.0001) as compared with the three groups with longer S2C intervals of 1 hour<S2C≤2 hours (OR 0.44, 95% CI 0.33 to 0.59, p<0.0001), 2 hours<S2C≤6 hours (OR 0.49, 95% CI 0.38 to 0.64, p<0.0001) and 6 hours<S2C≤24 hours (OR 0.42, 95% CI 0.30 to 0.58, p<0.0001).

Conclusions: Timely reperfusion with a contact-to-balloon time of less than 90 min is most effective in patients presenting with short S2C intervals of less than 1 hour, but has also beneficial effects in patients with S2C intervals of up to 24 hours.

Trial registration number: NCT00794001.

Keywords: acute coronary syndrome; chest pain; myocardial infarction.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Emergency Medical Services / methods*
  • Female
  • Hospital Mortality / trends
  • Humans
  • Incidence
  • Male
  • Percutaneous Coronary Intervention / methods*
  • Risk Factors
  • ST Elevation Myocardial Infarction / epidemiology
  • ST Elevation Myocardial Infarction / surgery*
  • Survival Rate / trends
  • Time Factors
  • Time-to-Treatment*
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT00794001